Several computational methodologies and biophysical techniques are being adapted and examples of successful designs are beginning to emerge. Simultaneously, there is a growing awareness of improving clinical trial designs using statistical and mathematical modeling to prevent unnecessary drug candidate failures. This book details the applications of computational and molecular modeling techniques towards affordable biopharmaceutical drug development at both pre-clinical and clinical stages.